XEN 45 GTS
Report
- Report Number
- 3011299751-2023-00009
- Event Type
- Injury
- Date Received
- January 23, 2023
- Date of Event
- November 10, 2022
- Report Date
- January 23, 2023
- Manufacturer
- ALLERGAN (IRVINE)
- Product Code
- KYF
- UDI-DI
- 10888628032439
- PMA / PMN Number
- K161457
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
(B)(4). ARTICLE CITATION: CREAGMILE J, KIM WI, SCOUARNEC C. HYDRUS MICROSTENT IMPLANTATION WITH OMNI SURGICAL SYSTEM AB INTERNO CANALOPLASTY FOR THE MANAGEMENT OF OPEN-ANGLE GLAUCOMA IN PHAKIC PATIENTS REFRACTORY TO MEDICAL THERAPY. AM J OPHTHALMOL CASE REP. 2022 NOV 10;29:101749. DOI: 10.1016/J.AJOC.2022.101749. PMID: 36544749; PMCID: PMC9762144. MULTIPLE REQUESTS FOR FURTHER INFORMATION HAVE BEEN MADE. ALLERGAN HAS RECEIVED NO RESPONSE FROM THE AUTHORS. THE EVENT IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT.
REPORTED EVENTS OF "XEN 45 GEL STENT IMPLANTATION THAT FAILED DESPITE BLEB NEEDLING REQUIRING AN AHMED VALVE, WHICH LATER FAILED. THE PATIENT WAS TAKING 4 MEDICATIONS (BRIMONIDINE, DORZOLAMIDE/TIMOLOL, LATANOPROST) WITH AN IOP OF 29 MMHG. THEY THEN UNDERWENT IMPLANTATION OF TWO HYDRUS MICROSTENTS WITH OMNI SURGICAL SYSTEM CANALOPLASTY." WERE NOTED IN THE ARTICLE: HYDRUS MICROSTENT IMPLANTATION WITH OMNI SURGICAL SYSTEM AB INTERNO CANALOPLASTY FOR THE MANAGEMENT OF OPEN-ANGLE GLAUCOMA IN PHAKIC PATIENTS REFRACTORY TO MEDICAL THERAPY. AM J OPHTHALMOL CASE REP. 29:101749. THIS IS THE SAME ARTICLE REPORTED UNDER MDR REPORT # 3011299751-2023-00008 (ALLERGAN COMPLAINT # (B)(4). THIS MDR IS BEING SUBMITTED FOR THE CASE 6.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 484216 | XEN 45 GTS | IMPLANT, EYE VALVE | KYF | ALLERGAN (IRVINE) | 5513-001 | NI | 10888628032439 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 55 YR | Male | Required Intervention |